147 related articles for article (PubMed ID: 4242214)
21. Antifungal agents.
Warin RP
Practitioner; 1974 Oct; 213(1276 SPEC NO):494-507. PubMed ID: 4617206
[No Abstract] [Full Text] [Related]
22. Butenafine: an update of its use in superficial mycoses.
Gupta AK
Skin Therapy Lett; 2002 Sep; 7(7):1-2, 5. PubMed ID: 12432425
[TBL] [Abstract][Full Text] [Related]
23. Fighting foot and toenail fungus.
Health News; 1999 Aug; 5(10):7. PubMed ID: 15352293
[No Abstract] [Full Text] [Related]
24. Treatment of dermatophytoses and pityriasis versicolor with itraconazole.
Panconesi E; Difonzo E
Rev Infect Dis; 1987; 9 Suppl 1():S109-13. PubMed ID: 3027833
[TBL] [Abstract][Full Text] [Related]
25. [Our experience with antimycotic therapy with Tolnaftate].
Nunzi E; Carbone G
Minerva Dermatol; 1968 May; 43(5):230-2. PubMed ID: 5705341
[No Abstract] [Full Text] [Related]
26. [Local treatment of skin and nail mycoses with Daktarin, a new broad-spectrum antifungal agent. Testing results of a group of dermatologists in practice].
Kull E
Schweiz Rundsch Med Prax; 1972 Oct; 61(42):1308-10. PubMed ID: 4263785
[No Abstract] [Full Text] [Related]
27. [Superficial mycoses in immunosuppressed patients].
Hernanz Hermosa JM; Lázaro Ochaita P
Rev Clin Esp; 1995 Oct; 195 Suppl 3():49-55. PubMed ID: 9441306
[No Abstract] [Full Text] [Related]
28. A reliable topical antifungal for podiatry.
Frohlich HT; Irons WG; Ceder ET
J Am Podiatry Assoc; 1967 Apr; 57(4):177-9. PubMed ID: 4227177
[No Abstract] [Full Text] [Related]
29. Management of onychomycosis and co-existing tinea pedis.
Lipner SR; Scher RK
J Drugs Dermatol; 2015 May; 14(5):492-4. PubMed ID: 25942668
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy studies of haloprogin, a new topical antimicrobial agent.
Hermann HW
Arch Dermatol; 1972 Dec; 106(6):839-42. PubMed ID: 4565229
[No Abstract] [Full Text] [Related]
31. Drugs for athlete's foot and tinea cruris.
Med Lett Drugs Ther; 1976 Nov; 18(24):101-2. PubMed ID: 1036605
[No Abstract] [Full Text] [Related]
32. Treatment of toenail tinea infection. True cure seems unlikely.
Buck DS
BMJ; 1996 Feb; 312(7026):312-3. PubMed ID: 8611806
[No Abstract] [Full Text] [Related]
33. The diagnosis and management of tinea.
Moriarty B; Hay R; Morris-Jones R
BMJ; 2012 Jul; 345():e4380. PubMed ID: 22782730
[No Abstract] [Full Text] [Related]
34. Onychomycosis and terbinafine.
Lancet; 1990 Mar; 335(8690):636. PubMed ID: 1969022
[No Abstract] [Full Text] [Related]
35. [Miconazol nitrate, a new broad spectrum antimycotic for local therapy in dermatomycoses. 3. Clinical results].
Refai M
Mykosen; 1973 Mar; 16(3):117-20. PubMed ID: 4576159
[No Abstract] [Full Text] [Related]
36. [Diabetic foot syndrome, 6. Diagnosis and treatment of mycoses].
Agathos M
MMW Fortschr Med; 2000 Nov; 142(44):38-9. PubMed ID: 11107803
[No Abstract] [Full Text] [Related]
37. Consumer preferences of antifungal products for treatment and prevention of tinea pedis.
Kang R; Lipner S
J Dermatolog Treat; 2019 Dec; 30(8):745-749. PubMed ID: 30661432
[TBL] [Abstract][Full Text] [Related]
38. [Tried and newly expanded local therapy of mycoses].
Kohler J
Mykosen; 1968 May; 11(5):391-4. PubMed ID: 5711948
[No Abstract] [Full Text] [Related]
39. Haloprogin for tinea.
Med Lett Drugs Ther; 1973 Aug; 15(17):69-70. PubMed ID: 4740517
[No Abstract] [Full Text] [Related]
40. [Antifungal properties of Freskin].
Rubisz-Brzezińska J; Noras A; Bendkowski W
Przegl Dermatol; 1978; 65(6):703-7. PubMed ID: 725112
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
